Unfortune see what's trending

31Mar/08

Cholesterol Drugs Take a Fall

The marketing of Vytorin and Zetia raced ahead of the science. Now Schering and Merck shareholders are $22 billion poorer

Filed under: Uncategorized Leave a comment
Comments (0) Trackbacks (0)

No comments yet.


Leave a comment

No trackbacks yet.